Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease

Practical Radiation Oncology

Volumn 3, Issue 4, 2013, Pages 316-322

  Corbin, Kimberly S ^a   Ranck, Mark C ^a   Hasselle, Michael D ^a   Golden, Daniel W ^a   Partouche, Julien ^a   Wu, Tianming ^a   Chmura, Steven J ^a   Weichselbaum, Ralph R ^a   Salama, Joseph K ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BLADDER CANCER; BONE METASTASIS; BREAST CANCER; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONTROLLED STUDY; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GROSS TUMOR VOLUME; HEAD AND NECK CANCER; HUMAN; HYPOFRACTIONATED IMAGE GUIDED RADIOTHERAPY; HYPOPHYSIS TUMOR; IMAGE GUIDED RADIOTHERAPY; KIDNEY CARCINOMA; LARGE VOLUME LIMITED METASTATIC DISEASE; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TOXICITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PATIENT SAFETY; PLANNING TARGET VOLUME; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; SARCOMA; SKIN TOXICITY; SOFT TISSUE METASTASIS; TUMOR VOLUME; UROGENITAL TRACT CANCER; VISCERAL METASTASIS;

EID: 84884352273     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.08.006     Document Type: Article

References (29)

1. Hellman S., Weichselbaum R.R. Oligometastases. J Clin Oncol 1995, 13:8-10.
2. Weichselbaum R.R., Hellman S. Oligometastases revisited. Nat Rev Clin Onco 2011, 8:378-382.
3. Park J.S., Kim H.K., Choi Y.S., et al. Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer. Ann Oncol 2010, 21:1285-1289.
4. Blackmon S.H., Shah N., Roth J.A., et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009, 88:877-885.
5. Fong Y., Fortner J., Sun R.L., Brennan M.F., Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-321.
6. Chang B.K., Timmerman R.D. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007, 30:637-644.
7. Milano M.T., Katz A.W., Muhs A.G., et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008, 112:650-658.
8. Rusthoven K.E., Kavanagh B.D., Cardenes H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578.
9. Rusthoven K.E., Kavanagh B.D., Burri S.H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584.
10. Salama J.K., Hasselle M.D., Chmura S.J., et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2012, 118:2962-2970.
11. Milano M.T., Katz A.W., Schell M.C., Philip A., Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:1516-1522.
12. Hof H., Hoess A., Oetzel D., Debus J., Herfarth K. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol 2007, 183:673-678.
13. Timmerman R.D. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008, 18:215-222.
14. Milano M.T., Constine L.S., Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008, 3:36.
15. Siva S., MacManus M., Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 2010, 5:1091-1099.
16. Chang E.L., Shiu A.S., Mendel E., et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 2007, 7:151-160.
17. Milano M.T., Philip A., Okunieff P. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses. Int J Radiat Oncol Biol Phys 2009, 73:832-837.
18. Hasselle M.D., Haraf D.J., Rusthoven K.E., et al. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol 2012, 7:376-381.
19. Milano M.T., Katz A.W., Zhang H., Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012, 83:878-886.
20. Chawla S., Chen Y., Katz A.W., et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009, 75:71-75.
21. Casamassima F., Livi L., Masciullo S., et al. Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol Biol Phys 2012, 82:919-923.
22. Katz A.W., Carey-Sampson M., Muhs A.G., Milano M.T., Schell M.C., Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007, 67:793-798.
23. McCammon R., Schefter T.E., Gaspar L.E., Zaemisch R., Gravdahl D., Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2009, 73:112-118.
24. Hamamoto Y., Kataoka M., Yamashita M., et al. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Jpn J Clin Oncol 2010, 40:125-129.
25. Wulf J., Haedinger U., Oppitz U., Thiele W., Mueller G., Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004, 60:186-196.
26. Nguyen Q.N., Shiu A.S., Rhines L.D., et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:1185-1192.
27. Okunieff P., Petersen A.L., Philip A., et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006, 45:808-817.
28. Benedict S.H., Yenice K.M., Followill D., et al. Stereotactic body radiotherapy: the report of AAPM Task Group 101. Med Phys 2010, 37:4078-4101.
29. Lee M.T., Kim J.J., Dinniwell R., et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27:1585-1591.